S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
S&P 500   4,280.15 (+1.73%)
DOW   33,761.05 (+1.27%)
QQQ   330.39 (+1.95%)
AAPL   172.10 (+2.14%)
MSFT   291.91 (+1.70%)
META   180.50 (+1.70%)
GOOGL   121.68 (+2.39%)
AMZN   143.55 (+2.07%)
TSLA   900.09 (+4.68%)
NVDA   187.09 (+4.27%)
NIO   21.11 (+1.39%)
BABA   94.77 (-0.11%)
AMD   100.83 (+2.76%)
MU   65.04 (+4.36%)
T   18.27 (+1.27%)
CGC   3.30 (+4.76%)
GE   79.93 (+1.31%)
F   16.18 (+2.21%)
DIS   121.57 (+3.30%)
AMC   24.44 (-3.97%)
PYPL   101.10 (+2.01%)
PFE   50.11 (+3.77%)
NFLX   249.30 (+2.72%)
NASDAQ:LFVN

LifeVantage - LFVN Stock Forecast, Price & News

$4.19
-0.09 (-2.10%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.11
$4.26
50-Day Range
$4.01
$4.89
52-Week Range
$3.80
$8.02
Volume
17,963 shs
Average Volume
42,163 shs
Market Capitalization
$52.75 million
P/E Ratio
5.99
Dividend Yield
2.80%
Price Target
N/A

LifeVantage MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.34% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
1.20mentions of LifeVantage in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

829th out of 1,117 stocks

Pharmaceutical Preparations Industry

416th out of 550 stocks

LFVN stock logo

About LifeVantage (NASDAQ:LFVN) Stock

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.

LifeVantage Stock Performance

NASDAQ:LFVN opened at $4.28 on Friday. The company has a market cap of $53.89 million, a P/E ratio of 6.11 and a beta of 1.21. The business's 50 day moving average price is $4.36 and its 200-day moving average price is $4.64. LifeVantage has a fifty-two week low of $3.80 and a fifty-two week high of $8.02.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on LifeVantage in a research report on Wednesday. They set a "buy" rating on the stock.

Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Stock News Headlines

LifeVantage (NASDAQ:LFVN) Now Covered by StockNews.com
See More Headlines
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Company Calendar

Last Earnings
11/04/2021
Ex-Dividend for 5/31 Dividend
5/16/2022
Dividend Payable
5/31/2022
Today
8/12/2022
Next Earnings (Confirmed)
8/23/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFVN
Employees
263
Year Founded
N/A

Profitability

Net Income
$12.89 million
Pretax Margin
5.79%

Debt

Sales & Book Value

Annual Sales
$220.18 million
Cash Flow
$1.47 per share
Book Value
$2.63 per share

Miscellaneous

Free Float
11,356,000
Market Cap
$52.75 million
Optionable
Optionable
Beta
1.21

Key Executives

  • Mr. Steven R. Fife (Age 61)
    Pres, CEO & Director
    Comp: $708.71k
  • Mr. Matthew Cooley (Age 48)
    Chief Operating Officer
    Comp: $194.07k
  • Ms. Alissa Neufeld (Age 43)
    Gen. Counsel & Corp. Sec.
    Comp: $393.95k
  • Mr. Carl Aure
    Chief Financial Officer
  • Mr. Eric E. Marchant
    VP of Compliance
  • Chris Taylor
    Director of Communications
  • Julie Boyster
    Chief Marketing Officer
  • Ms. Michelle Oborn-Virchow (Age 42)
    Sr. VP of HR
  • Ms. Calli Mott
    Sr. VP of Distributor Experience
  • Mr. Dave Fleming
    Sr. VP of Sales













LFVN Stock - Frequently Asked Questions

How have LFVN shares performed in 2022?

LifeVantage's stock was trading at $6.32 at the beginning of 2022. Since then, LFVN shares have decreased by 33.7% and is now trading at $4.19.
View the best growth stocks for 2022 here
.

When is LifeVantage's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 23rd 2022.
View our LFVN earnings forecast
.

How can I listen to LifeVantage's earnings call?

LifeVantage will be holding an earnings conference call on Tuesday, August 23rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13730454".

How were LifeVantage's earnings last quarter?

LifeVantage Co. (NASDAQ:LFVN) released its quarterly earnings results on Thursday, November, 4th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.21 by $0.02. The company earned $53.22 million during the quarter. LifeVantage had a net margin of 4.49% and a trailing twelve-month return on equity of 27.19%. During the same period last year, the company earned $0.25 EPS.

How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage?

LifeVantage declared a quarterly dividend on Tuesday, May 3rd. Stockholders of record on Tuesday, May 17th will be paid a dividend of $0.03 per share on Tuesday, May 31st. This represents a $0.12 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date of this dividend is Monday, May 16th.
Read our dividend analysis for LFVN
.

Is LifeVantage a good dividend stock?

LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.12 per share and currently has a dividend yield of 2.80%. The dividend payout ratio is 17.14%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for LFVN.

What is Darren Jensen's approval rating as LifeVantage's CEO?

5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees.

What other stocks do shareholders of LifeVantage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).

What is LifeVantage's stock symbol?

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

Who are LifeVantage's major shareholders?

LifeVantage's stock is owned by a variety of retail and institutional investors. Top institutional investors include Grantham Mayo Van Otterloo & Co. LLC (0.51%), Connor Clark & Lunn Investment Management Ltd. (0.27%), O Shaughnessy Asset Management LLC (0.19%), Private Advisor Group LLC (0.09%), Victory Capital Management Inc. (0.08%) and JPMorgan Chase & Co. (0.05%). Insiders that own company stock include Darren Jay Jensen, Justin Rose and Michael A Beindorff.
View institutional ownership trends
.

How do I buy shares of LifeVantage?

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeVantage's stock price today?

One share of LFVN stock can currently be purchased for approximately $4.19.

How much money does LifeVantage make?

LifeVantage (NASDAQ:LFVN) has a market capitalization of $52.75 million and generates $220.18 million in revenue each year. The company earns $12.89 million in net income (profit) each year or $0.70 on an earnings per share basis.

How many employees does LifeVantage have?

The company employs 263 workers across the globe.

How can I contact LifeVantage?

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The official website for the company is www.lifevantage.com. The company can be reached via phone at (801) 432-9000, via email at scott.vanwinkle@icrinc.com, or via fax at 801-880-0699.

This page (NASDAQ:LFVN) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.